secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sensus Healthcare, Inc. (SRTS)
CIK:        0001494891
Form:       8-K
Filed at:   2022-02-10T23:59:59+00:00
Accession:  0001213900-22-006461
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sensus Healthcare Q4 record revenue $13.0M, EPS $0.32; FY 2021 revenue $27.0M up 182%
--------------------------------------------------------------------------------

- Q4 revenue $13.0M (+156% YoY); net income $5.3M ($0.32 diluted EPS) vs $1.0M ($0.06) in Q4 2020.
- Full-year 2021 revenue $27.0M (+182%); diluted EPS $0.25 vs loss of $0.42 in 2020.
- Shipped record 35 systems in Q4, including 3 to China; received Ministry of Health license renewal through 2026.
- Signed exclusive U.S. distribution agreement for TransDermal Infusion System for needle-less drug delivery.
- Affirms expectation for Q1 2022 continued growth and full-year 2022 profitability.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1494891/000121390022006461/0001213900-22-006461-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1494891/000121390022006461/ea155130-8k_sensus.htm
  HTML page:      https://secwatch.observer/filing/0001213900-22-006461

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer